Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 14 | 2024 | 471 | 2.700 |
Why?
|
| ROC Curve | 16 | 2024 | 785 | 2.690 |
Why?
|
| Ultrasonography, Mammary | 5 | 2024 | 81 | 1.980 |
Why?
|
| Diagnosis, Computer-Assisted | 11 | 2018 | 334 | 1.980 |
Why?
|
| Breast Neoplasms | 16 | 2024 | 3053 | 1.970 |
Why?
|
| Sensitivity and Specificity | 18 | 2024 | 2009 | 1.340 |
Why?
|
| Image Interpretation, Computer-Assisted | 9 | 2020 | 693 | 1.120 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2020 | 3509 | 0.980 |
Why?
|
| Artificial Intelligence | 4 | 2020 | 358 | 0.770 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2010 | 471 | 0.670 |
Why?
|
| Prostatic Neoplasms | 14 | 2019 | 1771 | 0.670 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2020 | 1271 | 0.660 |
Why?
|
| Models, Statistical | 5 | 2013 | 578 | 0.640 |
Why?
|
| Observer Variation | 9 | 2024 | 612 | 0.590 |
Why?
|
| Calcinosis | 5 | 2007 | 230 | 0.580 |
Why?
|
| Breast Density | 1 | 2018 | 35 | 0.580 |
Why?
|
| Image Enhancement | 7 | 2020 | 562 | 0.580 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 9 | 2019 | 294 | 0.570 |
Why?
|
| Algorithms | 7 | 2013 | 1956 | 0.570 |
Why?
|
| Prostate | 6 | 2016 | 413 | 0.530 |
Why?
|
| Pattern Recognition, Automated | 4 | 2005 | 222 | 0.520 |
Why?
|
| Breast Diseases | 3 | 2006 | 101 | 0.470 |
Why?
|
| Contrast Media | 12 | 2020 | 1076 | 0.460 |
Why?
|
| Multimodal Imaging | 4 | 2016 | 115 | 0.440 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2013 | 203 | 0.440 |
Why?
|
| Axilla | 1 | 2013 | 105 | 0.420 |
Why?
|
| Monte Carlo Method | 4 | 2020 | 188 | 0.390 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 498 | 0.380 |
Why?
|
| Reproducibility of Results | 10 | 2020 | 2794 | 0.360 |
Why?
|
| Area Under Curve | 5 | 2013 | 337 | 0.350 |
Why?
|
| Retrospective Studies | 16 | 2020 | 9703 | 0.320 |
Why?
|
| Gadolinium DTPA | 7 | 2014 | 255 | 0.320 |
Why?
|
| Female | 23 | 2024 | 47893 | 0.320 |
Why?
|
| Radiologists | 2 | 2019 | 51 | 0.310 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 226 | 0.300 |
Why?
|
| Humans | 44 | 2024 | 92337 | 0.300 |
Why?
|
| Middle Aged | 22 | 2024 | 27030 | 0.300 |
Why?
|
| Aged | 21 | 2024 | 19943 | 0.290 |
Why?
|
| Diagnosis, Differential | 7 | 2020 | 1592 | 0.280 |
Why?
|
| Lung Neoplasms | 5 | 2019 | 2394 | 0.280 |
Why?
|
| Computer Simulation | 6 | 2013 | 1111 | 0.280 |
Why?
|
| Mass Screening | 2 | 2015 | 675 | 0.280 |
Why?
|
| Subtraction Technique | 2 | 2005 | 130 | 0.280 |
Why?
|
| Epidemiologic Research Design | 1 | 2007 | 22 | 0.270 |
Why?
|
| Tumor Burden | 4 | 2016 | 314 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 2680 | 0.270 |
Why?
|
| Precancerous Conditions | 2 | 2005 | 201 | 0.260 |
Why?
|
| Positron-Emission Tomography | 3 | 2016 | 341 | 0.240 |
Why?
|
| Radiology | 2 | 2016 | 205 | 0.230 |
Why?
|
| User-Computer Interface | 1 | 2006 | 187 | 0.230 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 123 | 0.220 |
Why?
|
| Models, Theoretical | 1 | 2006 | 497 | 0.210 |
Why?
|
| Adult | 14 | 2024 | 27532 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2016 | 1138 | 0.190 |
Why?
|
| Registries | 1 | 2007 | 902 | 0.190 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 1150 | 0.190 |
Why?
|
| Likelihood Functions | 3 | 2016 | 252 | 0.180 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 6916 | 0.180 |
Why?
|
| Automation | 2 | 2018 | 112 | 0.170 |
Why?
|
| Radiographic Image Enhancement | 3 | 2007 | 465 | 0.160 |
Why?
|
| Radiography, Thoracic | 2 | 2016 | 332 | 0.160 |
Why?
|
| Bayes Theorem | 2 | 2012 | 389 | 0.160 |
Why?
|
| Prostatectomy | 7 | 2019 | 479 | 0.160 |
Why?
|
| Early Detection of Cancer | 3 | 2019 | 469 | 0.160 |
Why?
|
| Breast | 1 | 2020 | 289 | 0.150 |
Why?
|
| Lupus Nephritis | 2 | 2016 | 77 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2016 | 608 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 1763 | 0.140 |
Why?
|
| Nephritis, Interstitial | 1 | 2016 | 44 | 0.130 |
Why?
|
| Probability | 2 | 2016 | 357 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2019 | 806 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 209 | 0.120 |
Why?
|
| Prospective Studies | 1 | 2024 | 4468 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 142 | 0.120 |
Why?
|
| Whole Body Imaging | 1 | 2015 | 40 | 0.120 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 142 | 0.120 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2016 | 139 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2019 | 2369 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2016 | 476 | 0.110 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 32 | 0.110 |
Why?
|
| Male | 19 | 2019 | 43925 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2014 | 139 | 0.100 |
Why?
|
| Prostatic Hyperplasia | 2 | 2013 | 91 | 0.100 |
Why?
|
| Seminal Vesicles | 1 | 2013 | 39 | 0.100 |
Why?
|
| Carcinoma | 1 | 2016 | 438 | 0.100 |
Why?
|
| Kidney | 2 | 2016 | 1145 | 0.100 |
Why?
|
| Computer Graphics | 1 | 2012 | 100 | 0.100 |
Why?
|
| Inflammation | 2 | 2016 | 1025 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 2035 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 341 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2013 | 246 | 0.090 |
Why?
|
| Neoplasm Grading | 3 | 2019 | 390 | 0.090 |
Why?
|
| Biopsy | 3 | 2019 | 1194 | 0.080 |
Why?
|
| Apoptosis | 1 | 2016 | 1743 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2015 | 901 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 5430 | 0.080 |
Why?
|
| Radiography | 1 | 2010 | 795 | 0.070 |
Why?
|
| Liver | 1 | 2013 | 1228 | 0.070 |
Why?
|
| Software | 2 | 2015 | 675 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 767 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2004 | 376 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 1807 | 0.060 |
Why?
|
| Normal Distribution | 1 | 2005 | 38 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2006 | 90 | 0.060 |
Why?
|
| Meglumine | 2 | 2016 | 38 | 0.060 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 33 | 0.060 |
Why?
|
| Decision Making | 1 | 2009 | 680 | 0.050 |
Why?
|
| Organometallic Compounds | 2 | 2016 | 142 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2016 | 900 | 0.050 |
Why?
|
| Quality Control | 1 | 2003 | 117 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 1191 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 600 | 0.050 |
Why?
|
| Alopecia | 1 | 2002 | 35 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2002 | 29 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2002 | 130 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 1919 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 661 | 0.040 |
Why?
|
| Prognosis | 2 | 2016 | 3872 | 0.030 |
Why?
|
| Models, Biological | 1 | 2004 | 1786 | 0.030 |
Why?
|
| Mice, Inbred NZB | 1 | 2016 | 13 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 20 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2016 | 25 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 2016 | 32 | 0.030 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 43 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 800 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 2016 | 88 | 0.030 |
Why?
|
| Germinal Center | 1 | 2016 | 61 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 122 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 97 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 283 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 172 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 441 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 410 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 184 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 923 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 3775 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2016 | 328 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 45 | 0.030 |
Why?
|
| United States | 1 | 2007 | 7348 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 133 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 6624 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2013 | 92 | 0.030 |
Why?
|
| Cell Communication | 1 | 2014 | 205 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 1550 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2013 | 66 | 0.030 |
Why?
|
| Gadolinium | 1 | 2013 | 104 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 866 | 0.020 |
Why?
|
| Rectum | 1 | 2013 | 149 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 569 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1927 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2016 | 1110 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 566 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 863 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 754 | 0.020 |
Why?
|
| Carcinoma, Ductal | 1 | 2007 | 18 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 12110 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1239 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 2978 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2007 | 160 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1576 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 9504 | 0.010 |
Why?
|
| Keratin-14 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Keratins | 1 | 2002 | 64 | 0.010 |
Why?
|
| Transgenes | 1 | 2002 | 184 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 28003 | 0.010 |
Why?
|
| Homeostasis | 1 | 2002 | 450 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 968 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 1312 | 0.010 |
Why?
|
| Calcium | 1 | 2002 | 1183 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2002 | 2087 | 0.010 |
Why?
|